NAFDAC REG NO: A4-101222 Médicament
About the medicine: Brimonidine tartrate: uses, dosage and brands worldwide
Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.
Relieves redness of the eye due to minor eye irritations
you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days
For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.
Label for brimonidine tartrate, the active ingredient registered with NAFDAC.
Add the expiry date on your pack for a full Trust Score.
Brimosopt 0.2% Eye Drop contains Brimonidine Tartrate (0.2%), as eye drops, according to its NAFDAC registration record.
Yes. Brimosopt 0.2% Eye Drop is listed on the NAFDAC register under registration number A4-101222, and its registration is active as of 6 November 2026.
No WHO falsified or substandard medical product alert currently matches Brimosopt 0.2% Eye Drop in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A4-101222, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Follow your prescription or the leaflet in your pack. The official label says: adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch …
relieves redness of the eye due to minor eye irritations (Summarised from the official U.S. FDA label for brimonidine tartrate. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.